Use of DurogesicD-TRANS in Cancer Pain Patients With Inadequately Controlled Pain Relief From Weak Opioids.

Trial Profile

Use of DurogesicD-TRANS in Cancer Pain Patients With Inadequately Controlled Pain Relief From Weak Opioids.

Completed
Phase of Trial: Phase IV

Latest Information Update: 25 Apr 2013

At a glance

  • Drugs Fentanyl (Primary)
  • Indications Cancer pain
  • Focus Therapeutic Use
  • Sponsors Janssen
  • Most Recent Events

    • 02 Mar 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
    • 02 Mar 2010 Actual initiation date (March 2007) and actual patient number (143) added as reported by ClinicalTrials.gov.
    • 02 Mar 2010 Actual end date (December 2008) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top